Skin Cancer Treatment Market Size, Trends, and Forecast to 2031
Skin Cancer Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Melanoma and Non-Melanoma); Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy, and Others); End User (Hospitals, Dermatology Clinics, Diagnostic and Cancer Care Centers, and Others); and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
- Status : Published
- Report Code : TIPRE00038949
- Category : Life Sciences
- No. of Pages : 241
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Therapy, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The skin cancer treatment market is estimated to reach a value of US$ 19.53 billion by 2031.
North America dominated the market in 2024.
The skin cancer treatment market is estimated to register a CAGR of 7.57% during the forecast period.
Merck KGaAPfizer Inc, Novartis AG, Bristol-Myers Squibb Co, Amgen Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, GSK Plc, Iovance Biotherapeutics Inc, Genentech Inc are among the key players operating in the skin cancer treatment market.
The increasing incidence of skin cancer and rising product approvals are among the noteworthy factors contributing to the market growth.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Skin Cancer Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Skin Cancer Treatment Market – Key Market Dynamics
5.1 Skin Cancer Treatment Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Incidence of Skin Cancer
5.2.2 Expanding Approvals and Pipeline of Advanced Therapies
5.3 Market Restraints
5.3.1 High Costs of Skin Cancer Treatment
5.4 Market Opportunities
5.4.1 Personalized and Combination Therapies
5.5 Future Trends
5.5.1 Shift Toward Precision and Patient?Centered Therapies
5.6 Impact of Drivers and Restraints:
6. Skin Cancer Treatment Market – Global Market Analysis
6.1 Skin Cancer Treatment Market Revenue (US$ Million), 2021–2031
6.2 Skin Cancer Treatment Market Forecast Analysis
7. Skin Cancer Treatment Market Analysis – by Type
7.1 Melanoma
7.1.1 Overview
7.1.2 Melanoma: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Non Melanoma
7.2.1 Overview
7.2.2 Non Melanoma: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
8. Skin Cancer Treatment Market Analysis – by Therapy
8.1 Immunotherapy
8.1.1 Overview
8.1.2 Immunotherapy: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Targeted Therapy
8.2.1 Overview
8.2.2 Targeted Therapy: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Chemotherapy
8.3.1 Overview
8.3.2 Chemotherapy: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Radiation Therapy
8.4.1 Overview
8.4.2 Radiation Therapy: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
9. Skin Cancer Treatment Market Analysis – by End User
9.1 Dermatology Clinics
9.1.1 Overview
9.1.2 Dermatology Clinics: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Hospitals
9.2.1 Overview
9.2.2 Hospitals: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic and Cancer Care Center
9.3.1 Overview
9.3.2 Diagnostic and Cancer Care Center: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
10. Skin Cancer Treatment Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Skin Cancer Treatment Market Overview
10.2.2 North America: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.2.3 North America: Skin Cancer Treatment Market Breakdown, by Type
10.2.3.1 North America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Type
10.2.4 North America: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.2.4.1 North America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Non Melanoma
10.2.5 North America: Skin Cancer Treatment Market Breakdown, by Therapy
10.2.5.1 North America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Therapy
10.2.6 North America: Skin Cancer Treatment Market Breakdown, by End User
10.2.6.1 North America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by End User
10.2.7 North America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.2.7.1 North America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.2.7.2 United States: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.7.2.1 United States: Skin Cancer Treatment Market Breakdown, by Type
10.2.7.2.2 United States: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.2.7.2.3 United States: Skin Cancer Treatment Market Breakdown, by Therapy
10.2.7.2.4 United States: Skin Cancer Treatment Market Breakdown, by End User
10.2.7.3 Canada: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.7.3.1 Canada: Skin Cancer Treatment Market Breakdown, by Type
10.2.7.3.2 Canada: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.2.7.3.3 Canada: Skin Cancer Treatment Market Breakdown, by Therapy
10.2.7.3.4 Canada: Skin Cancer Treatment Market Breakdown, by End User
10.2.7.4 Mexico: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.7.4.1 Mexico: Skin Cancer Treatment Market Breakdown, by Type
10.2.7.4.2 Mexico: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.2.7.4.3 Mexico: Skin Cancer Treatment Market Breakdown, by Therapy
10.2.7.4.4 Mexico: Skin Cancer Treatment Market Breakdown, by End User
10.3 Europe
10.3.1 Europe Skin Cancer Treatment Market Overview
10.3.2 Europe: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.3.3 Europe: Skin Cancer Treatment Market Breakdown, by Type
10.3.3.1 Europe: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Type
10.3.4 Europe: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.3.4.1 Europe: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Non Melanoma
10.3.5 Europe: Skin Cancer Treatment Market Breakdown, by Therapy
10.3.5.1 Europe: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Therapy
10.3.6 Europe: Skin Cancer Treatment Market Breakdown, by End User
10.3.6.1 Europe: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by End User
10.3.7 Europe: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.3.7.1 Europe: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.3.7.2 Germany: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.7.2.1 Germany: Skin Cancer Treatment Market Breakdown, by Type
10.3.7.2.2 Germany: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.3.7.2.3 Germany: Skin Cancer Treatment Market Breakdown, by Therapy
10.3.7.2.4 Germany: Skin Cancer Treatment Market Breakdown, by End User
10.3.7.3 France: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.7.3.1 France: Skin Cancer Treatment Market Breakdown, by Type
10.3.7.3.2 France: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.3.7.3.3 France: Skin Cancer Treatment Market Breakdown, by Therapy
10.3.7.3.4 France: Skin Cancer Treatment Market Breakdown, by End User
10.3.7.4 United Kingdom: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.7.4.1 United Kingdom: Skin Cancer Treatment Market Breakdown, by Type
10.3.7.4.2 United Kingdom: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.3.7.4.3 United Kingdom: Skin Cancer Treatment Market Breakdown, by Therapy
10.3.7.4.4 United Kingdom: Skin Cancer Treatment Market Breakdown, by End User
10.3.7.5 Italy: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.7.5.1 Italy: Skin Cancer Treatment Market Breakdown, by Type
10.3.7.5.2 Italy: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.3.7.5.3 Italy: Skin Cancer Treatment Market Breakdown, by Therapy
10.3.7.5.4 Italy: Skin Cancer Treatment Market Breakdown, by End User
10.3.7.6 Spain: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.7.6.1 Spain: Skin Cancer Treatment Market Breakdown, by Type
10.3.7.6.2 Spain: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.3.7.6.3 Spain: Skin Cancer Treatment Market Breakdown, by Therapy
10.3.7.6.4 Spain: Skin Cancer Treatment Market Breakdown, by End User
10.3.7.7 Rest of Europe: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.7.7.1 Rest of Europe: Skin Cancer Treatment Market Breakdown, by Type
10.3.7.7.2 Rest of Europe: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.3.7.7.3 Rest of Europe: Skin Cancer Treatment Market Breakdown, by Therapy
10.3.7.7.4 Rest of Europe: Skin Cancer Treatment Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific Skin Cancer Treatment Market Overview
10.4.2 Asia Pacific: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.4.3 Asia Pacific: Skin Cancer Treatment Market Breakdown, by Type
10.4.3.1 Asia Pacific: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Type
10.4.4 Asia Pacific: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.4.4.1 Asia Pacific: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Non Melanoma
10.4.5 Asia Pacific: Skin Cancer Treatment Market Breakdown, by Therapy
10.4.5.1 Asia Pacific: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Therapy
10.4.6 Asia Pacific: Skin Cancer Treatment Market Breakdown, by End User
10.4.6.1 Asia Pacific: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by End User
10.4.7 Asia Pacific: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.4.7.1 Asia Pacific: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.4.7.2 China: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.7.2.1 China: Skin Cancer Treatment Market Breakdown, by Type
10.4.7.2.2 China: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.4.7.2.3 China: Skin Cancer Treatment Market Breakdown, by Therapy
10.4.7.2.4 China: Skin Cancer Treatment Market Breakdown, by End User
10.4.7.3 Japan: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.7.3.1 Japan: Skin Cancer Treatment Market Breakdown, by Type
10.4.7.3.2 Japan: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.4.7.3.3 Japan: Skin Cancer Treatment Market Breakdown, by Therapy
10.4.7.3.4 Japan: Skin Cancer Treatment Market Breakdown, by End User
10.4.7.4 India: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.7.4.1 India: Skin Cancer Treatment Market Breakdown, by Type
10.4.7.4.2 India: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.4.7.4.3 India: Skin Cancer Treatment Market Breakdown, by Therapy
10.4.7.4.4 India: Skin Cancer Treatment Market Breakdown, by End User
10.4.7.5 Australia: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.7.5.1 Australia: Skin Cancer Treatment Market Breakdown, by Type
10.4.7.5.2 Australia: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.4.7.5.3 Australia: Skin Cancer Treatment Market Breakdown, by Therapy
10.4.7.5.4 Australia: Skin Cancer Treatment Market Breakdown, by End User
10.4.7.6 South Korea: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.7.6.1 South Korea: Skin Cancer Treatment Market Breakdown, by Type
10.4.7.6.2 South Korea: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.4.7.6.3 South Korea: Skin Cancer Treatment Market Breakdown, by Therapy
10.4.7.6.4 South Korea: Skin Cancer Treatment Market Breakdown, by End User
10.4.7.7 Rest of APAC: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.7.7.1 Rest of APAC: Skin Cancer Treatment Market Breakdown, by Type
10.4.7.7.2 Rest of APAC: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.4.7.7.3 Rest of APAC: Skin Cancer Treatment Market Breakdown, by Therapy
10.4.7.7.4 Rest of APAC: Skin Cancer Treatment Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa Skin Cancer Treatment Market Overview
10.5.2 Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.5.3 Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Type
10.5.3.1 Middle East and Africa: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Type
10.5.4 Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.5.4.1 Middle East and Africa: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Non Melanoma
10.5.5 Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Therapy
10.5.5.1 Middle East and Africa: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Therapy
10.5.6 Middle East and Africa: Skin Cancer Treatment Market Breakdown, by End User
10.5.6.1 Middle East and Africa: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by End User
10.5.7 Middle East and Africa: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.5.7.1 Middle East and Africa: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.5.7.2 Saudi Arabia: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.7.2.1 Saudi Arabia: Skin Cancer Treatment Market Breakdown, by Type
10.5.7.2.2 Saudi Arabia: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.5.7.2.3 Saudi Arabia: Skin Cancer Treatment Market Breakdown, by Therapy
10.5.7.2.4 Saudi Arabia: Skin Cancer Treatment Market Breakdown, by End User
10.5.7.3 South Africa: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.7.3.1 South Africa: Skin Cancer Treatment Market Breakdown, by Type
10.5.7.3.2 South Africa: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.5.7.3.3 South Africa: Skin Cancer Treatment Market Breakdown, by Therapy
10.5.7.3.4 South Africa: Skin Cancer Treatment Market Breakdown, by End User
10.5.7.4 United Arab Emirates: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.7.4.1 United Arab Emirates: Skin Cancer Treatment Market Breakdown, by Type
10.5.7.4.2 United Arab Emirates: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.5.7.4.3 United Arab Emirates: Skin Cancer Treatment Market Breakdown, by Therapy
10.5.7.4.4 United Arab Emirates: Skin Cancer Treatment Market Breakdown, by End User
10.5.7.5 Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.7.5.1 Rest of Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Type
10.5.7.5.2 Rest of Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.5.7.5.3 Rest of Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Therapy
10.5.7.5.4 Rest of Middle East and Africa: Skin Cancer Treatment Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America Skin Cancer Treatment Market Overview
10.6.2 South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
10.6.3 South and Central America: Skin Cancer Treatment Market Breakdown, by Type
10.6.3.1 South and Central America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Type
10.6.4 South and Central America: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.6.4.1 South and Central America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Non Melanoma
10.6.5 South and Central America: Skin Cancer Treatment Market Breakdown, by Therapy
10.6.5.1 South and Central America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Therapy
10.6.6 South and Central America: Skin Cancer Treatment Market Breakdown, by End User
10.6.6.1 South and Central America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by End User
10.6.7 South and Central America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.6.7.1 South and Central America: Skin Cancer Treatment Market – Revenue and Forecast Analysis – by Country
10.6.7.2 Brazil: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.7.2.1 Brazil: Skin Cancer Treatment Market Breakdown, by Type
10.6.7.2.2 Brazil: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.6.7.2.3 Brazil: Skin Cancer Treatment Market Breakdown, by Therapy
10.6.7.2.4 Brazil: Skin Cancer Treatment Market Breakdown, by End User
10.6.7.3 Argentina: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.7.3.1 Argentina: Skin Cancer Treatment Market Breakdown, by Type
10.6.7.3.2 Argentina: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.6.7.3.3 Argentina: Skin Cancer Treatment Market Breakdown, by Therapy
10.6.7.3.4 Argentina: Skin Cancer Treatment Market Breakdown, by End User
10.6.7.4 Rest of South and Central America: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.7.4.1 Rest of South and Central America: Skin Cancer Treatment Market Breakdown, by Type
10.6.7.4.2 Rest of South and Central America: Skin Cancer Treatment Market Breakdown, by Non Melanoma
10.6.7.4.3 Rest of South and Central America: Skin Cancer Treatment Market Breakdown, by Therapy
10.6.7.4.4 Rest of South and Central America: Skin Cancer Treatment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12. Global Skin Cancer Treatment Market Industry Landscape
12.1 Overview
12.2 Product Launch, Product Approvals
12.3 Expansions And Other Strategic Developments
13. Company Profiles
13.1 Merck KGaA
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Pfizer Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Novartis AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bristol-Myers Squibb Co
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Amgen Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Hoffmann-La Roche Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Regeneron Pharmaceuticals Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 GSK Plc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Iovance Biotherapeutics Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Sun Pharmaceutical Industries Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Skin Cancer Treatment Market Segmentation
Table 2. Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million)
Table 3. Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 4. Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 5. Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 6. Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 7. Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 8. Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 9. Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 10. North America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 11. North America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 12. North America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 13. North America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 14. North America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 15. North America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 16. North America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 17. North America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 18. North America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 19. North America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 20. United States: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 21. United States: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 22. United States: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 23. United States: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 24. United States: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 25. United States: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 26. United States: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 27. United States: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 28. Canada: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 29. Canada: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 30. Canada: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 31. Canada: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 32. Canada: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 33. Canada: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 34. Canada: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 35. Canada: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 36. Mexico: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 37. Mexico: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 38. Mexico: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 39. Mexico: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 40. Mexico: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 41. Mexico: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 42. Mexico: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 43. Mexico: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 44. Europe: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 45. Europe: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 46. Europe: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 47. Europe: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 48. Europe: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 49. Europe: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 50. Europe: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 51. Europe: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 52. Europe: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 53. Europe: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 54. Germany: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 55. Germany: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 56. Germany: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 57. Germany: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 58. Germany: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 59. Germany: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 60. Germany: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 61. Germany: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 62. France: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 63. France: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 64. France: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 65. France: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 66. France: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 67. France: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 68. France: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 69. France: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 70. United Kingdom: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 71. United Kingdom: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 72. United Kingdom: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 73. United Kingdom: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 74. United Kingdom: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 75. United Kingdom: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 76. United Kingdom: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 77. United Kingdom: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 78. Italy: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 79. Italy: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 80. Italy: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 81. Italy: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 82. Italy: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 83. Italy: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 84. Italy: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 85. Italy: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 86. Spain: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 87. Spain: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 88. Spain: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 89. Spain: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 90. Spain: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 91. Spain: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 92. Spain: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 93. Spain: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 94. Rest of Europe: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 95. Rest of Europe: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 96. Rest of Europe: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 97. Rest of Europe: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 98. Rest of Europe: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 99. Rest of Europe: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 100. Rest of Europe: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 101. Rest of Europe: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 102. Asia Pacific: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 103. Asia Pacific: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 104. Asia Pacific: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 105. Asia Pacific: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 106. Asia Pacific: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 107. Asia Pacific: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 108. Asia Pacific: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 109. Asia Pacific: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 110. Asia Pacific: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 111. Asia Pacific: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 112. China: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 113. China: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 114. China: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 115. China: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 116. China: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 117. China: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 118. China: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 119. China: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 120. Japan: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 121. Japan: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 122. Japan: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 123. Japan: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 124. Japan: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 125. Japan: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 126. Japan: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 127. Japan: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 128. India: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 129. India: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 130. India: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 131. India: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 132. India: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 133. India: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 134. India: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 135. India: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 136. Australia: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 137. Australia: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 138. Australia: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 139. Australia: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 140. Australia: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 141. Australia: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 142. Australia: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 143. Australia: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 144. South Korea: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 145. South Korea: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 146. South Korea: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 147. South Korea: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 148. South Korea: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 149. South Korea: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 150. South Korea: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 151. South Korea: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 152. Rest of APAC: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 153. Rest of APAC: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 154. Rest of APAC: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 155. Rest of APAC: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 156. Rest of APAC: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 157. Rest of APAC: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 158. Rest of APAC: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 159. Rest of APAC: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 160. Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 161. Middle East and Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 162. Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 163. Middle East and Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 164. Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 165. Middle East and Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 166. Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 167. Middle East and Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 168. Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 169. Middle East and Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 170. Saudi Arabia: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 171. Saudi Arabia: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 172. Saudi Arabia: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 173. Saudi Arabia: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 174. Saudi Arabia: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 175. Saudi Arabia: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 176. Saudi Arabia: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 177. Saudi Arabia: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 178. South Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 179. South Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 180. South Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 181. South Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 182. South Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 183. South Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 184. South Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 185. South Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 186. United Arab Emirates: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 187. United Arab Emirates: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 188. United Arab Emirates: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 189. United Arab Emirates: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 190. United Arab Emirates: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 191. United Arab Emirates: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 192. United Arab Emirates: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 193. United Arab Emirates: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 194. Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 195. Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 196. Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 197. Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 198. Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 199. Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 200. Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 201. Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 202. South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 203. South and Central America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 204. South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 205. South and Central America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 206. South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 207. South and Central America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 208. South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 209. South and Central America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 210. South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 211. South and Central America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 212. Brazil: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 213. Brazil: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 214. Brazil: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 215. Brazil: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 216. Brazil: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 217. Brazil: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 218. Brazil: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 219. Brazil: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 220. Argentina: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 221. Argentina: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 222. Argentina: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 223. Argentina: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 224. Argentina: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 225. Argentina: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 226. Argentina: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 227. Argentina: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 228. Rest of South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 229. Rest of South and Central America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 230. Rest of South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Non Melanoma
Table 231. Rest of South and Central America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Non Melanoma
Table 232. Rest of South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by Therapy
Table 233. Rest of South and Central America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy
Table 234. Rest of South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 235. Rest of South and Central America: Skin Cancer Treatment Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 236. Heat Map Analysis by Key Players
List of Figures
Figure 1. Skin Cancer Treatment Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Skin Cancer Treatment Market Revenue (US$ Million), 2021–2031
Figure 5. Skin Cancer Treatment Market Share (%) – by Type (2024 and 2031)
Figure 6. Melanoma: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Non Melanoma: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Skin Cancer Treatment Market Share (%) – by Therapy (2024 and 2031)
Figure 9. Immunotherapy: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Targeted Therapy: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Chemotherapy: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Radiation Therapy: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Skin Cancer Treatment Market Share (%) – by End User (2024 and 2031)
Figure 15. Dermatology Clinics: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Hospitals: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Diagnostics Center: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Others: Skin Cancer Treatment Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Skin Cancer Treatment Market Breakdown by Region, 2024 and 2031 (%)
Figure 20. North America: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 21. North America: Skin Cancer Treatment Market Breakdown, by Type (2024 and 2031)
Figure 22. North America: Skin Cancer Treatment Market Breakdown, by Non Melanoma (2024 and 2031)
Figure 23. North America: Skin Cancer Treatment Market Breakdown, by Therapy (2024 and 2031)
Figure 24. North America: Skin Cancer Treatment Market Breakdown, by End User (2024 and 2031)
Figure 25. North America: Skin Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 26. United States: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 27. Canada: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 28. Mexico: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 29. Europe: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 30. Europe: Skin Cancer Treatment Market Breakdown, by Type (2024 and 2031)
Figure 31. Europe: Skin Cancer Treatment Market Breakdown, by Non Melanoma (2024 and 2031)
Figure 32. Europe: Skin Cancer Treatment Market Breakdown, by Therapy (2024 and 2031)
Figure 33. Europe: Skin Cancer Treatment Market Breakdown, by End User (2024 and 2031)
Figure 34. Europe: Skin Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 35. Germany: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 36. France: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 37. United Kingdom: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 38. Italy: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 39. Spain: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 40. Rest of Europe: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 41. Asia Pacific: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 42. Asia Pacific: Skin Cancer Treatment Market Breakdown, by Type (2024 and 2031)
Figure 43. Asia Pacific: Skin Cancer Treatment Market Breakdown, by Non Melanoma (2024 and 2031)
Figure 44. Asia Pacific: Skin Cancer Treatment Market Breakdown, by Therapy (2024 and 2031)
Figure 45. Asia Pacific: Skin Cancer Treatment Market Breakdown, by End User (2024 and 2031)
Figure 46. Asia Pacific: Skin Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 47. China: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 48. Japan: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 49. India: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 50. Australia: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 51. South Korea: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 52. Rest of APAC: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 53. Middle East and Africa: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 54. Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Type (2024 and 2031)
Figure 55. Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Non Melanoma (2024 and 2031)
Figure 56. Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Therapy (2024 and 2031)
Figure 57. Middle East and Africa: Skin Cancer Treatment Market Breakdown, by End User (2024 and 2031)
Figure 58. Middle East and Africa: Skin Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 59. Saudi Arabia: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 60. South Africa: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 61. United Arab Emirates: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 62. Rest of Middle East and Africa: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 63. South and Central America: Skin Cancer Treatment Market – Revenue, 2021–2031 (US$ Million)
Figure 64. South and Central America: Skin Cancer Treatment Market Breakdown, by Type (2024 and 2031)
Figure 65. South and Central America: Skin Cancer Treatment Market Breakdown, by Non Melanoma (2024 and 2031)
Figure 66. South and Central America: Skin Cancer Treatment Market Breakdown, by Therapy (2024 and 2031)
Figure 67. South and Central America: Skin Cancer Treatment Market Breakdown, by End User (2024 and 2031)
Figure 68. South and Central America: Skin Cancer Treatment Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 69. Brazil: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 70. Argentina: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 71. Rest of South and Central America: Skin Cancer Treatment Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 72. Company Positioning & Concentration
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For